UK medicines supply disruption and ongoing MHRA oversight highlight why businesses need continuous GDP compliance support and operational review.
Let’s route your enquiry to the right place.
Your information will only be used by us in line with our Privacy Notice.
Let’s route your enquiry to the right place.
Your information will only be used by us in line with our Privacy Notice.
UK medicines supply disruption and ongoing MHRA oversight highlight why businesses need continuous GDP compliance support and operational review.
Global medicines supply pressure is increasing regulatory and operational risk. Learn why compliance route reviews matter for GDP and WDA(H) operations.
UK medicines wholesale is growing, but compliance failures still trigger regulatory action. Learn why WDA(H) readiness and ongoing GDP compliance are critical.
Recent UK regulatory action highlights the risks of weak compliance oversight. Learn why Responsible Person and GDP quality support are critical.
A recent MHRA medicine recall shows why wholesalers need strong GDP systems, traceability, Responsible Person oversight and recall readiness.
MHRA inspections remain risk-based across UK medicines wholesale. Learn why GDP audit and readiness support is critical for compliance and WDA(H) holders.
UK healthcare supply pressures show why medicines wholesale businesses need clear GDP, supplier, customer and distribution planning before entering regulated activity.
© 2026 TPMG Group Ltd. All rights reserved. TPMG Group Ltd is the commercial and operating hub within the wider TPMG Group. Company number: 14618789. Registered office: Cardinal Point, Park Road, Rickmansworth, WD3 1RE.